Corvus Pharmaceuticals Inc CRVS:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
2.30quote price arrow up+0.01 (+0.44%)
Volume
7,317
Close
2.29quote price arrow up+0.10 (+4.57%)
Volume
244,387
52 week range
1.05 - 4.19
Loading...
  • Open2.16
  • Day High2.34
  • Day Low2.11
  • Prev Close2.19
  • 52 Week High4.19
  • 52 Week High Date06/09/23
  • 52 Week Low1.05
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap143.242M
  • Shares Out62.55M
  • 10 Day Average Volume0.54M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change30.11

KEY STATS

  • Open2.16
  • Day High2.34
  • Day Low2.11
  • Prev Close2.19
  • 52 Week High4.19
  • 52 Week High Date06/09/23
  • 52 Week Low1.05
  • 52 Week Low Date10/30/23
  • Market Cap143.242M
  • Shares Out62.55M
  • 10 Day Average Volume0.54M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change30.11

RATIOS/PROFITABILITY

  • EPS (TTM)-0.51
  • P/E (TTM)-4.48
  • Fwd P/E (NTM)-4.56
  • EBITDA (TTM)-22.969M
  • ROE (TTM)-60.46%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Corvus Pharmaceuticals Inc

 

Profile

MORE
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of ITK inhibition as a new approach to immunotherapy for a range of cancer and immune diseases. Its lead product candidate is soquelitinib, a selective, covalent inhibitor of ITK (interleukin 2 inducible T cell kinase) and is in a multi-center Phase 1/1b clinical trial in patients with various recurrent, malignant T cell lymphomas. Soquelitinib is designed to...
Richard Miller M.D.
Chairman of the Board, President, Chief Executive Officer
Leiv Lea
Chief Financial Officer
Address
863 Mitten Rd Ste 102
Burlingame, CA
94010-1311
United States

Top Peers

SYMBOLLASTCHG%CHG
BCAB
Bioatla Inc
2.83-0.27-8.71%
PDSB
PDS Biotechnology Corp
3.49-0.04-1.13%
CTXR
Citius Pharmaceuticals Inc
0.6484-0.0191-2.8614%
ACET
Adicet Bio Inc
1.60+0.03+1.91%
RZLT
Rezolute Inc
2.64+0.08+3.12%